Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.26587 | 69 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.4724 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.40586 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.10683 | 75 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.51929 | 79 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.53306 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.84785 | 75 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.97387 | 75 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.01653 | 75 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.63964 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.03302 | 76 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.94596 | 75 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.55629 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.1726 | 68 |